Pharmacie Fonze SRL
Pharmacie Fonze reported total assets of 726,488 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jul 2026).
The score of Pharmacie Fonze shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +8 % Total assets +12 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacie Fonze's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 78,443 € | ||||
| Equity | 638,556 € | ||||
| Cash | 1,690 € | ||||
| EBITDA | 129,534 € | ||||
| Total assets | 726,488 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 14 Jun 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 02 Jun 2022
Pharmacie Fonze's financial analysis
- Solvency87.9%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacie Fonze
Pharmacie Fonze's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0476.642.954
- VAT number
- BE0476642954
- Peppol
- Registered · 0208:0476642954 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Jan 2002
- Registered office
- 4624 Fléron
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Pharmacie Fonze (SRL) has been based in Fléron since 2002, active in: activities of holding companies. For 2025, it reports a net profit of 78,443 € and equity of 638,556 €; its revenue is not published. Its solvency stands at 87.9%, above the median of its sector (46.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacie Fonze
Companies in the same business, of comparable size and area, outside its group.
- Henly Activities of holding companies Kortemark · balance sheet 726,220 €
- Jerso Activities of holding companies Harelbeke · balance sheet 726,837 €
- CUM Laude Maxima Activities of holding companies Brasschaat · balance sheet 727,745 €
- Macors Management SPRL Activities of holding companies Ciney · balance sheet 727,797 €
- Beger Consulting Activities of holding companies Zelzate · balance sheet 728,117 €
- Simron Activities of holding companies Laakdal · balance sheet 724,541 €
- Ardiva Activities of holding companies Namur · balance sheet 728,446 €
- Pharmtheek Activities of holding companies Tubize · balance sheet 724,385 €
Frequently asked questions about Pharmacie Fonze
What is the revenue of Pharmacie Fonze?
Pharmacie Fonze files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacie Fonze?
In Belgium, the VAT number is the company number prefixed with BE: BE0476642954 for Pharmacie Fonze, if the company is VAT-registered. Its company number (CBE) is 0476.642.954.
Where is the registered office of Pharmacie Fonze?
According to the CBE register, the registered office of Pharmacie Fonze is in 4624 Fléron.
What is the equity of Pharmacie Fonze?
At the close of the 2025 financial year, the equity of Pharmacie Fonze amounts to 638,556 €, a solvency of 87.9% of total assets.
Who manages Pharmacie Fonze?
The register lists 1 active mandates at Pharmacie Fonze. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacie Fonze
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →